Asston Pharmaceuticals Ltd

BSE: 544445

2

total announcements

544445.BO · 15 min delayed

BSEAGM/EGM23h ago

Asston Pharmaceuticals Ltd

Voting Result and Scrutinizer report for EGM held on 31st July, 2026 through VC-OAVM

Asston Pharmaceuticals Ltd has announced the voting results and scrutinizer's report for its Extraordinary General Meeting (EGM) held on July 31, 2026, through video conferencing. The meeting was attended by 3 promoters and 0 public shareholders, and 1 resolution was passed, which was to issue equity shares on a preferential basis.

Read more →📎 1 attachment
BSEAGM/EGM4d ago

Asston Pharmaceuticals Ltd

Outcome and Proceedings of the 2nd Extraordinary General Meeting for F.Y. 2026-27, scheduled to be held on 31st July, 2026, at 12:30 P.M. through Video Conferencing and Other Audio-Visual Means.

Asston Pharmaceuticals Ltd held its 2nd Extraordinary General Meeting on 31st July, 2026, via video conferencing, to discuss and pass resolutions. The meeting was conducted in accordance with the circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. The requisite quorum was present, and the resolutions were taken as read with the consent of the members. The company provided its members with the facility to cast their vote electronically through the NSDL system before the meeting and also made available the remote e-voting facility from 28th July, 2026, to 30th July, 2026.

Read more →📎 1 attachment